Halbert Hargrove Global Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4
| Closed | -$1.59K | – | 417 |
|
|
2025
Q1 | $1.59K | Buy |
+4
| New | +$1.61K | ﹤0.01% | 419 |
|
|
2023
Q2 | – | Sell |
-822
| Closed | -$378K | – | 120 |
|
|
2023
Q1 | $378K | Buy |
822
+26
| +3% | +$12.4K | 0.03% | 92 |
|
|
2022
Q4 | $408K | Sell |
796
-83
| -9% | -$42.1K | 0.03% | 87 |
|
|
2022
Q3 | $399K | Sell |
879
-1
| -0.1% | -$478 | 0.03% | 85 |
|
|
2022
Q2 | $425K | Buy |
880
+6
| +0.7% | +$2.97K | 0.03% | 80 |
|
|
2022
Q1 | $430K | Buy |
874
+38
| +5% | +$17.4K | 0.03% | 87 |
|
|
2021
Q4 | $387K | Buy |
836
+126
| +18% | +$53K | 0.02% | 96 |
|
|
2021
Q3 | $265K | Sell |
710
-15
| -2% | -$5.7K | 0.02% | 115 |
|
|
2021
Q2 | $277K | Buy |
725
+8
| +1% | +$3.06K | 0.02% | 118 |
|
|
2021
Q1 | $257K | Buy |
717
+20
| +3% | +$6.43K | 0.02% | 106 |
|
|
2020
Q4 | $224K | Buy |
+697
| New | +$214K | 0.02% | 105 |
|
|
2019
Q3 | – | Sell |
-708
| Closed | -$200K | – | 89 |
|
|
2019
Q2 | $200K | Sell |
708
-5
| -0.7% | -$1.37K | 0.05% | 79 |
|
|
2019
Q1 | $205K | Buy |
+713
| New | +$206K | 0.79% | 42 |
|
|
2018
Q4 | – | Sell |
-735
| Closed | -$201K | – | 84 |
|
|
2018
Q3 | $201K | Buy |
+735
| New | +$191K | 0.05% | 73 |
|
|
2016
Q1 | – | Sell |
-1,838
| Closed | -$256K | – | 83 |
|
|
2015
Q4 | $256K | Sell |
1,838
-47
| -2% | -$6.47K | 0.11% | 77 |
|
|
2015
Q3 | $264K | Sell |
1,885
-2,063
| -52% | -$310K | 0.13% | 68 |
|
|
2015
Q2 | $648K | Sell |
3,948
-650
| -14% | -$104K | 0.16% | 53 |
|
|
2015
Q1 | $710K | Buy |
4,598
+1,882
| +69% | +$268K | 0.23% | 50 |
|
|
2014
Q4 | $341K | Sell |
2,716
-1,570
| -37% | -$194K | 0.17% | 71 |
|
|
2014
Q3 | $513K | Buy |
4,286
+21
| +0.5% | +$2.41K | 0.14% | 54 |
|
|
2014
Q2 | $459K | Buy |
4,265
+1,127
| +36% | +$116K | 0.14% | 49 |
|
|
2014
Q1 | $312K | Sell |
3,138
-62
| -2% | -$5.61K | 0.1% | 79 |
|
|
2013
Q4 | $296K | Buy |
+3,200
| New | +$284K | 0.09% | 93 |
|